جست‌وجوی استاد و پژوهشگر

Michael F. Bergerمشاهده پروفایل

استادیار

• Cancer Biology
• Omics
• Bioinformatics
• +۵ مورد دیگر

Michael F. Berger is an Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences and Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center (MSKCC). He serves as the inaugural Chief of the Clinical Computational Diagnostics Service in the Department of Pathology and Laboratory Medicine at MSKCC. Education: PhD in Biophysics from Harvard University; Bachelor’s in Physics from Princeton University Research Interests: Berger specializes in genomic and computational techniques to identify molecular drivers of cancer and develop targeted therapies. His work focuses on biomarker discovery, tumor evolution, and clinical implementation of next-generation sequencing assays like MSK-IMPACT (FDA-authorized tumor profiling) and MSK-ACCESS (liquid biopsy). Recent Articles: His publications highlight population-scale clinical genomic datasets, integrating mutational signatures, clonality, and ancestry in cancer progression. Key trends include applications of machine learning, liquid biopsies, and genome-derived tumor typing for personalized medicine. Grants & Collaborations: Berger collaborates with clinical leaders at MSKCC, leveraging large-scale sequencing data for translational research. His lab explores inherited variants, clonal hematopoiesis, and drug resistance mechanisms through clinical partnerships. Labs & Teams: He leads the Michael Berger Lab at MSKCC, part of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences.

• Biomedical Engineering
• Medical Imaging
• Cancer Research
• +۷ مورد دیگر

Amoon Jamzad is an Adjunct Assistant Professor at the School of Computing, Queen's University, and a postdoctoral fellow at Med-I Lab. He holds a BSc in Electrical Engineering (Electronics) from University of Tehran (2007), an MSc in Biomedical Engineering (2010), and a PhD in Biomedical Engineering (2015). His doctoral research focused on noninvasive ultrasound analysis of kidney stones. He later served as a guest lecturer and lab instructor at University of Tehran for 3 years before joining Queen's University in 2019. BSc: Electrical Engineering (Electronics), University of Tehran (2007) MSc: Biomedical Engineering, University of Tehran (2010) PhD: Biomedical Engineering, University of Tehran (2015) Dr. Jamzad's research centers on cancer cell detection, particularly in developing ultrasonic and optical spectroscopic devices for surgical margin detection. His work integrates advanced machine learning techniques with clinical applications, focusing on breast and prostate cancer surgery. He has pioneered the use of mass spectrometry imaging for cancer margin assessment and developed open-source platforms like ViPRE and MassVision for AI-driven medical data analysis. His recent publications demonstrate expertise in self-supervised learning, domain adaptation, and uncertainty quantification within medical imaging contexts. While no specific awards are mentioned, his contributions to surgical oncology tools and multi-center prostate cancer studies indicate significant clinical impact. He has also explored temporal enhanced ultrasound for composite defect detection and electrosurgical cautery state recognition through deep learning.

Keshab K. Parhiمشاهده پروفایل

استاد

• VLSI Signal Processing
• Machine Learning
• Biomedical Signal/Image Processing
• +۶ مورد دیگر

Keshab Parhi is the Distinguished McKnight University Professor and inaugural Erwin A. Kelen Chair in Electrical Engineering at the University of Minnesota's College of Engineering. He has been a permanent faculty member since 1988 and serves as Editor-in-Chief of the IEEE Circuits and Systems Magazine. B.Tech., IIT Kharagpur (1982) M.S., University of Pennsylvania (1984) Ph.D., UC Berkeley (1988) His research spans VLSI architecture design for signal processing, machine learning , biomedical systems , homomorphic encryption , and DNA/molecular computing . Key projects include high-speed transceivers, low-power bio-signal classification, and novel cryptographic architectures. Recent publications focus on homomorphic encryption for privacy-preserving AI, hyperdimensional computing for energy-efficient classification, and neural network accelerators with pipelined architectures. Scientific Awards IEEE Fellow (1996) IEEE Kiyo Tomiyasu Award (2003) IEEE W.R.G. Baker Prize (2001) ACM Fellow (2020) AIMBE Fellow (2022) National Academy of Inventors (2020) Dr. Parhi has advised 52 PhD students and 65+ MS/MEng theses, while leading the Parhi Research Group. His work contributes to UN SDGs through advancements in low-power computing and medical diagnostics .

Rene Jackstadtمشاهده پروفایل

پژوهشگر

• Cancer Progression and Metastasis
• Stem Cell Biology
• Colorectal Cancer
• +۳ مورد دیگر

Rene Jackstadt is a Junior Research Group Leader at the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) . His research focuses on cancer progression and metastasis , particularly in colorectal cancer , with a strong emphasis on stem cell biology , Wnt signaling , and epithelial-mesenchymal transition . He leads the Cancer Progression and Metastasis research group within the Normal and Malignant Stem Cells program. Position: HI-STEM Junior Research Group Leader Location: Im Neuenheimer Feld 280, Heidelberg, Germany Contact: r.jackstadt@hi-stem.de His work involves advanced organoid modeling and genetic manipulation to study tumor evolution and therapeutic vulnerabilities. Current projects explore: Stromal interactions in metastasis Immune checkpoint regulation Tumor microenvironment dynamics Signal transduction in oncogenesis Publications highlight his contributions to understanding: Wnt pathway in cancer MicroRNA regulation of MYC Stress-induced stem cell activation Tumor-immune co-evolution His team includes: PhD Students: Luisa Nader, Manuel Mastel, Gabriele Diamante, Nikolaos Georgakopoulos, Aitana Guiseris Martinez Research Assistant: Raja Flüchter

• Ophthalmology
• Vitreoretinal Surgery
• Retinal Diseases
• +۴ مورد دیگر

Aman Chandra is a consultant ophthalmic and vitreoretinal surgeon, Honorary Visiting Fellow at the Vision and Eye Research Institute (Faculty of Health, Medicine and Social Care, School of Medicine), and an active researcher in retinal diseases and zonular disorders. He holds affiliations with institutions including the Mid & South Essex NHS Foundation Trust, Royal College of Ophthalmologists, Royal College of Surgeons of Edinburgh, and international societies like EURETINA and American Society of Retinal Specialists. Clinical Training: Moorfields Eye Hospital (London), Royal Victoria Eye & Ear Hospital (Melbourne) Education: PhD in Genetics of Rhegmatogenous Retinal Detachment & Ectopia Lentis (University College London, Institute of Ophthalmology), MBBS (Guy’s, King’s & St Thomas’ Hospitals), BSc (Pharmacology, King’s College London) Research Interests focus on retinal diseases, zonular disorders, and their genetic underpinnings. He has led clinical trials, secured over £100,000 in grants, and collaborated globally across the USA, India, Australia, and the UK. His work intersects ophthalmology, molecular genetics, and surgical education. Recent Publications highlight trends in vitreoretinal surgery during the COVID-19 pandemic, genetic studies of retinal detachment, and surgical training methodologies. Key keywords include ophthalmic genetics, retinal surgery, and clinical trial design. Scientific Awards include the prestigious Syme Medal (2015) from the Royal College of Surgeons of Edinburgh, Fight For Sight Small Project Award, Ethicon and Pfizer Travel Awards, and significant grant funding. Teaching & Leadership : He develops and leads clinical courses at Anglia Ruskin University (ARU), national meetings, and international conferences. Roles include Surgical Trainer (Royal College of Ophthalmologists), Simulation Trainer (European School for Advanced Studies in Ophthalmology), and Faculty on Get it Flat course (American Society of Retinal Specialists). Labs & Teams : Collaborates globally with institutions in the USA, India, Australia, and UK. Served as Ophthalmology Council Member (Royal Society of Medicine), Awards and Scholarships Lead (Royal College of Ophthalmologists), and Immediate Past Research Lead for BEAVRS. He reviews manuscripts for Eye , IOVS , and other journals.

• Microbiology
• Actinomycetes
• Atacama Desert Microbiology
• +۶ مورد دیگر

Dr. Barbara Andrews is a researcher in the Department of Chemical Engineering at the Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile. Her work focuses on the microbiology of extreme environments, particularly the Atacama Desert, and biochemical separation techniques. She has maintained a consistent research output for over two decades with recent publications extending into 2024. Her primary research interests center on the study of actinomycetes and other extremophiles from the Atacama Desert, one of Earth's most arid environments. Dr. Andrews investigates their taxonomic classification, metabolic capabilities, and biotechnological potential. She also maintains a strong research program in protein separation technologies, particularly aqueous two-phase systems, which has produced influential review articles in the field. Her work bridges fundamental microbiology with practical biotechnological applications, including antibiotic discovery, enzyme production, and microbial contributions to plant growth. Analysis of her recent publication trends shows a clear focus on the microbial ecology of the Atacama Desert, with particular attention to actinomycetes and their unique adaptations to extreme aridity. Her research spans taxonomic studies, metabolic modeling, and the bioprospecting of novel compounds with potential pharmaceutical applications. The interdisciplinary nature of her work connects microbiology, chemical engineering, and environmental science. Dr. Andrews has maintained a productive research program through consistent collaborations, particularly with Dr. Juan Asenjo and other researchers at Universidad de Chile. Her work demonstrates sustained funding support, though specific grant details are not provided in the available publications. She has contributed to special journal issues focused on Atacama Desert microbiology, indicating her recognized expertise in this niche field. Her laboratory appears to focus on the isolation and characterization of extremophilic microorganisms from the Atacama Desert, with particular emphasis on their metabolic capabilities and potential biotechnological applications. The research team likely maintains culture collections of desert microorganisms and employs both traditional microbiological techniques and modern genomic approaches in their investigations.

Priya P. Alexanderمشاهده پروفایل

مدرس پزشکی

• Renal pathology
• Molecular basis of renal disease
• Biomarker discovery
• +۳ مورد دیگر

Priya P. Alexander, M.D. , is an anatomic pathologist at the Mayo Clinic College of Medicine , affiliated with the Department of Laboratory Medicine and Pathology in Rochester, Minnesota.

Ande M. Rumillaمشاهده پروفایل

استاد

• Molecular Pathology
• Genetic Pathology
• Anatomic Pathology
• +۴ مورد دیگر

Dr. Ande M. Rumilla is a distinguished pathologist at Mayo Clinic in Rochester, Minnesota, specializing in Laboratory Medicine and Pathology with a focus on Anatomic Pathology. She holds appointments in the Mayo Clinic College of Medicine and serves as an active researcher and clinician within the Department of Laboratory Medicine and Pathology. Her educational background includes a BA in Biology from the University of Chicago (1999) and an MD from the University of Illinois College of Medicine at Chicago (2004). She completed her residency training in Anatomic and Clinical Pathology (2008) followed by a fellowship in Molecular Genetic Pathology (2010), all at Mayo Clinic. Dr. Rumilla's research spans molecular pathology, genetic diagnostics, and precision medicine with particular expertise in cancer genomics, molecular diagnostics, and epigenetic analysis. Her work bridges basic science with clinical applications, focusing on developing and validating molecular assays for improved patient care. She has made significant contributions to understanding tumor mutation burden, BRAF/RAS signaling pathways, and molecular characterization of various cancers. Her publication record shows a clear trend toward increasingly sophisticated molecular techniques, from traditional pathology to next-generation sequencing, liquid biopsy analysis, and computational approaches to molecular diagnostics. Recent work emphasizes pan-cancer biomarker detection, methylation disorder classification, and validation of clinical molecular assays. Young Investigator Award from the Association for Molecular Pathology (2009) Dr. Rumilla actively contributes to professional societies including the Association for Molecular Pathology (since 2009), College of American Pathologists, United States and Canadian Academy of Pathology, and American Society for Clinical Pathology. She has participated in developing consensus guidelines for cell-free DNA assay validation, demonstrating leadership in establishing standards for molecular diagnostics. Her collaborative research extends across multiple Mayo Clinic departments and external institutions, reflecting the interdisciplinary nature of modern molecular pathology.

Maria Adelita A. Vizcaino Villalobosمشاهده پروفایل

استادیار

• Neuropathology
• Ophthalmic Pathology
• Anatomic Pathology
• +۳ مورد دیگر

Maria Adelita A. Vizcaino Villalobos is an Assistant Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine, specializing in Anatomic Pathology with dual expertise in Neuropathology and Ophthalmic Pathology. Her clinical and academic work focuses on CNS tumor diagnostics, molecular pathology, and rare ocular pathologies. Dr. Vizcaino Villalobos completed her medical education at Facultad de Medicina, UNAM (2008), followed by an Anatomic Pathology residency at Hospital General de México (2011). She pursued specialized training with multiple visiting clinician positions at John Hopkins University School of Medicine (2013-2015), a Post-doctoral Fellowship in Ophthalmic Pathology (2019), and completed her Anatomic Pathology/Neuropathology residency at Mayo Clinic in 2023. She is board certified in both Anatomic Pathology and Neuropathology by the American Board of Pathology. Her research interests span multiple disciplines within neuropathology and ophthalmic pathology, with particular focus on CNS tumor classification, molecular diagnostics, and rare ocular pathologies. Her work integrates histopathological analysis with advanced molecular techniques to improve diagnostic accuracy and understanding of disease mechanisms. She has made significant contributions to the understanding of pleomorphic xanthoastrocytoma, ganglioglioma transformation, and rare CNS tumor mimics. Analysis of her recent publications reveals a strong focus on diagnostic challenges in neuropathology, with emphasis on molecular characterization of CNS tumors, rare tumor entities, and the integration of histopathological features with molecular and epigenetic data. Her work bridges clinical practice with research, often focusing on cases that present diagnostic challenges or represent rare disease manifestations. 2023 Top rated poster: Reducing Defects to Decedents During Postmortem Examination (Mayo Clinic Rochester) 2023 Nominee for the AP Outstanding Educator Award-Resident or Fellow Multiple Diagnostic Slide Session awards from American Association of Neuropathologists Multiple Wilmer research grant awards from The Johns Hopkins University Dr. José Laguna García Teaching merit of excellence award (UNAM) Dr. Vizcaino Villalobos maintains active involvement in multiple professional organizations including the American Association of Neuropathologists, College of American Pathologists, and specialty societies focused on ophthalmic pathology. Her collaborative research approach is evident in her extensive co-authorship network across Mayo Clinic, Johns Hopkins, and international institutions. She serves on multiple committees including the Education Committee of the American Association of Neuropathologists and the Scientific Committee of the Mexican College and Association of Pathologists.

Rumeal D. Whaleyمشاهده پروفایل

استادیار

• Pathology
• Genitourinary Pathology
• Head and Neck Pathology
• +۵ مورد دیگر

Rumeal D. Whaley, M.D. is a faculty member in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, specializing in Anatomic Pathology. He completed his medical training at University of Louisville and pursued fellowships in Genitourinary Pathology at Indiana University and Head and Neck Pathology at Cleveland Clinic. His educational background includes: 2022: Fellow - Genitourinary Pathology, Indiana University 2021: Fellow - Head and Neck Pathology, Cleveland Clinic 2020: Residency - Anatomic & Clinical Pathology, Indiana University School of Medicine 2016: MD - Distinction in Research, University of Louisville School of Medicine 2011: BA, University of Louisville Dr. Whaley's research focuses on specialized areas of pathology including genitourinary tumors, head and neck pathology, endocrine pathology, and molecular characterization of various neoplasms. His work frequently involves immunohistochemical analysis, molecular profiling, and the study of rare tumor entities. He has made significant contributions to understanding renal cell carcinomas, thyroid pathology, penile squamous cell carcinoma, and various rare tumor types through his extensive publication record. His research trends show a strong emphasis on molecular pathology techniques, biomarker discovery, and the characterization of rare tumor entities across multiple organ systems. Recent publications highlight his expertise in applying advanced genomic and immunohistochemical techniques to better classify and understand tumor behavior. Among his notable recognitions: 2025 UroToday "Beyond the Abstract" Feature 2022 Excellence in Research, Indiana University School of Medicine 2020 Best Resident Case Study Poster Finalist, American Society for Clinical Pathology 2020 Society of '67 Open Access Award, Association of Pathology Chairs 2019 Excellence in Pathology Resident Teaching, Indiana University Dr. Whaley serves on multiple professional committees including as an abstract reviewer for the American Society for Clinical Pathology and is actively involved in collaborative pathology initiatives between Mayo Clinic and other institutions. His professional memberships span numerous pathology organizations including the Endocrine Pathology Society, Minnesota Society of Pathologists, and the Society of Black Pathology. He participates in the ProMedica & Mayo Clinic-Anatomic Pathology ePath Live Collaboration and the Sanford & Mayo Clinic-Anatomic Pathology ePath Live Collaboration, demonstrating his engagement in innovative telepathology approaches and collaborative diagnostic practices.

Tsung-Teh Wuمشاهده پروفایل

استاد

• Gastrointestinal Pathology
• Liver Pathology
• Esophageal Pathology
• +۴ مورد دیگر

Dr. Tsung-Teh Wu is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic Alix School of Medicine. His clinical and research focus lies at the intersection of gastrointestinal pathology, hepatology, and molecular diagnostics. With over two decades of experience, Dr. Wu has established himself as a leading expert in the histopathological evaluation of gastrointestinal and hepatic disorders. National Taiwan University College of Medicine (BM, 1985) National Taiwan University (MS, Pathology, 1987) University of Pennsylvania (PhD, Pathology, 1991) University of Pittsburgh (Residency & Chief Residency, Pathology, 1994-1995) Johns Hopkins University (Fellowship, Gastrointestinal Pathology, 1996) Dr. Wu's research interests encompass a broad spectrum of gastrointestinal pathology, with particular expertise in celiac disease, microscopic colitis, Barrett's esophagus, hepatocellular adenomas, and various liver pathologies. His work bridges the gap between basic science and clinical practice, with numerous publications that have significantly advanced the understanding of diagnostic criteria, molecular markers, and histopathological features of gastrointestinal diseases. His recent work demonstrates a strong commitment to developing standardized diagnostic approaches and translating research findings into clinical practice. Analysis of Dr. Wu's recent publications reveals a strong focus on diagnostic criteria standardization, molecular characterization of gastrointestinal and hepatic pathologies, and development of novel diagnostic approaches. His work spans from basic histopathological studies to multicenter clinical trials, demonstrating his commitment to translating research findings into clinical practice. Key themes include molecular characterization of liver tumors, standardization of diagnostic criteria for celiac disease, and development of non-endoscopic detection methods for Barrett's esophagus. Best Paper by Pathologists-In-Training Award, Stowell-Orbison, USCAP Meeting (2004) Runner-Up Award for the Best Presentation by a Resident, Gastrointestinal Pathology Society, USCAP Meeting (2000) Award for the Best Presentation by a Resident, Gastrointestinal Pathology Society, USCAP Meeting (2000) Yeh-Su Pathology Award (1987) Dr. Wu has served in leadership roles within several professional organizations, including as President of the Washington DC Chapter of the Society of Chinese Bioscientists in America. He is an active member of the American Gastroenterological Association, American Association for Cancer Research, and the Gastrointestinal Pathology Society. His research has been supported by various institutional grants, and he serves on the Upper GI Cancer Tissue Bank Committee and the Institutional Research Grants Program at the University of Texas M.D. Anderson Cancer Center. Dr. Wu's contributions to gastrointestinal pathology continue to shape diagnostic standards and improve patient care through evidence-based pathology practices.

Eunhee S. Yiمشاهده پروفایل

استاد

• Pulmonary Pathology
• Interstitial Lung Diseases
• Lung Transplant Pathology
• +۴ مورد دیگر

Dr. Eunhee S. Yi is a distinguished Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science in Rochester, Minnesota. With over three decades of experience in pulmonary pathology, she has established herself as a leading expert in interstitial lung diseases, lung transplant pathology, and lung cancer diagnostics. Her clinical work focuses on anatomic pathology with particular expertise in complex pulmonary cases requiring multidisciplinary approaches. Dr. Yi's educational background includes: MD from Seoul National University College of Medicine (1982) Pre-Medical from Seoul National University College of Medicine (1978) MS in Pathology from Seoul National University College of Medicine (1985) PhD coursework in Pathology from Seoul National University College of Medicine (1986) Residency in Anatomic Pathology at Seoul National University Hospital (1986) Residency in Anatomic Pathology at Washington Hospital Center (1990) Residency in Clinical Pathology at University of California, Irvine (1992) Dr. Yi's research focuses on pulmonary pathology with particular expertise in interstitial lung diseases, lung transplant pathology, and lung cancer diagnostics. Her work bridges clinical pathology with translational research, developing novel diagnostic approaches for complex pulmonary conditions. She has made significant contributions to understanding IgG4-related lung disease, pulmonary Langerhans cell histiocytosis, and the pathological features of various interstitial lung diseases. Her research often involves multidisciplinary collaborations with pulmonologists, radiologists, and thoracic surgeons to improve diagnostic accuracy and patient outcomes. Analysis of Dr. Yi's recent publications (2023-2025) reveals a strong focus on translational pathology with emphasis on direct patient-pathologist interactions, advanced diagnostic techniques including immunohistochemistry and genetic testing, and refinement of disease classification systems. Her work demonstrates a consistent trajectory toward integrating traditional pathology with modern molecular diagnostics and artificial intelligence to enhance precision medicine in pulmonary diseases. Dr. Yi has received several prestigious awards recognizing her contributions to pathology education and clinical practice: 2006 Teaching Award for Anatomic Pathology Faculty, University of California 2003 Pathology residents' teaching award for Anatomic Pathology Faculty 1989 Pathology residents' presentation award, Washington Society of Pathologists Throughout her career, Dr. Yi has been actively involved in professional societies including the United States and Canadian Academy of Pathology, American Society for Investigative Pathology, American Thoracic Society, and North American Society of Head and Neck Pathology. She has served on numerous committees including the Nominating Committee of the Pulmonary Pathology Society, Graduate Medical Education Committee at University of California, San Diego, and various quality assurance and research committees. Her mentorship has helped shape the careers of many pathology residents and fellows specializing in pulmonary pathology.

Cody S. Carterمشاهده پروفایل

استادیار

• Pathology
• Anatomic Pathology
• Clinical Pathology
• +۴ مورد دیگر

Cody S. Carter, MD is an Assistant Professor in the Pathology and Human Anatomy Department, Pathology Division at Loma Linda University School of Medicine. He also serves as Assistant Dean for Basic Science Education within the School of Medicine. Dr. Carter is board certified by the American Board of Pathology in both Anatomic Pathology and Clinical Pathology. Dr. Carter's research focuses on surgical pathology with particular expertise in soft tissue tumors, breast pathology, and molecular diagnostics. His work encompasses diagnostic challenges in mesenchymal neoplasms, tumor classification, and the application of immunohistochemistry in diagnostic pathology. He has made significant contributions to understanding rare tumors including ossifying fibromyxoid tumors, biphenotypic sinonasal sarcoma, and various soft tissue lesions. His publication record spans from 2010 to 2023, demonstrating consistent scholarly activity in high-impact pathology journals. His research shows a clear trajectory from early work in neurosurgical complications and facial aging to his current focus on molecular pathology and tumor classification. Dr. Carter frequently collaborates with colleagues at Loma Linda University and other institutions, particularly in the areas of soft tissue tumors and breast pathology. Diplomate, American Board of Pathology Board Certification in Anatomic Pathology and Clinical Pathology Graduate, Leadership Institute (ASCP) Graduate, Laboratory Management University (ASCP) Graduate, Healthcare Administration Scholars Program (University of Michigan) As Assistant Dean for Basic Science Education, Dr. Carter plays a significant role in medical education, particularly in hematology and immunology instruction as evidenced by his teaching schedule. His professional development includes extensive participation in medical education conferences through the International Association of Medical Science Educators (IAMSE) and pathology leadership forums.

Younes Smaniمشاهده پروفایل

استاد

• Microbiology
• Antimicrobial Resistance
• Bacterial Pathogenesis
• +۳ مورد دیگر

Dr. Younes Smani is a Professor at Pablo de Olavide University , leading the Expresión Génica en Bacterias de Interés Medioambiental research group at the Andalusian Center of Developmental Biology (CABD) . His work focuses on Microbiology , particularly antimicrobial resistance mechanisms in Gram-negative bacilli like Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacterales . Key Research Areas : Host-pathogen interactions, outer membrane protein targets (e.g., OmpA), and development of novel antibiotic classes targeting bacterial enzymes like enolase. Methodology : In vitro studies, animal models, proteomics, and computational approaches for drug discovery. Recent Publications highlight advancements in antimicrobial strategies , including AI-driven antibiotic discovery, enolase-targeting compounds, and repurposing drugs like tamoxifen metabolites. His team emphasizes combination therapies with existing antibiotics and anti-virulence approaches to combat resistance.

Santa Olga Cacciolaمشاهده پروفایل

استاد

• Plant Pathology
• Oomycetes
• Fungal Diseases
• +۷ مورد دیگر

Santa Olga Cacciola is a Full Professor of Plant Pathology at the University of Catania , Italy, with over 30 years of experience in plant pathology, molecular diagnostics, and sustainable disease management. She is internationally recognized for her expertise in Phytophthora diseases, citrus pathology, and bioremediation strategies using fungi and oomycetes. She has coordinated and participated in numerous EU and international projects, including PRIMA, PROMETEO, and COST Actions, and has served on editorial boards of leading journals such as Plant Disease , Plants (MDPI) , and Journal of Fungi . Education and Career: PhD in Plant Pathology – University of Bari Postdoctoral fellowships: University of Bern (Roche Foundation), Johns Hopkins University (NIH), and SCRI UK (OECD/OECE) Associate Professor – University of Palermo (1998–2008) Full Professor – University of Catania (2008–present) National Habilitation as Full Professor – ASN 2012 & 2013 Research Interests: Her research spans plant pathology , molecular diagnostics , bioremediation , and biological control . Key areas include: Phytophthora and fungal diseases of citrus and Mediterranean crops Molecular phylogeny and diagnostics of plant pathogens Metagenomics of plant pathogens Colletotrichum anthracnose on olive Genetic variability of pathogen populations Bioremediation using filamentous fungi Plant-pathogen-antagonist molecular interactions Scientific Awards and Recognitions: Fulbright Grant (2017–2018) VQR Evaluation: Score 1 (Excellent) Top Scientist Award – University of Catania (2005–2009) Research evaluation excellence – Italian National Agency Advising and Grants: She has supervised numerous PhD and Master’s students and has served on doctoral committees across multiple universities. She has coordinated or participated in over 20 national and international projects, including PRIMA, PROMETEO, COST Actions, and Erasmus+. Labs and Teams: She leads a research group at the Department of Agriculture, Food and Environment (Di3A) , University of Catania, and collaborates extensively with international institutions such as UC Berkeley, Johns Hopkins, USDA, and The James Hutton Institute.